Barriers to Adherence to Highly Active Antiretroviral Therapy As Expressed by People Living with HIV/AIDS

1999 ◽  
Vol 13 (9) ◽  
pp. 535-544 ◽  
Author(s):  
VERNON E. PROCTOR ◽  
ASRAT TESFA ◽  
DAVID C. TOMPKINS
2018 ◽  
Vol 4 (1) ◽  
pp. 43-52
Author(s):  
David Ufuoma Adje ◽  
Felicia Esemekiphorar Williams ◽  
Chukwuka Nicholas Bezugbe ◽  
Dauda Audi Dangiwa

Background:       Adherence to Highly Active Antiretroviral Therapy (HAART) is critical in achieving treatment goals, avoiding antimicrobial resistance, preventing treatment failure and improving the patient’s quality of life. Objectives: To assess the knowledge of antiretroviral therapy (ART) and adherence to antiretroviral (ARVs) medicines amongst People Living With HIV/AIDS (PLWHA) accessing care in two Nigerian Military HIV/AIDS Treatment sites. Methods: Four hundred patients on HAART who visited the study sites during the study period were recruited for the study using systematic random sampling method. A semi-structured, pretested, interviewer-administered questionnaire was used to obtain demographic details. Patients’ knowledge of HIV was assessed using an 8-item questionnaire while adherence was measured using the Simplified Medication Adherence Questionnaire (SMAQ). Results: The predominant age group was 31-40 years (46.4%). There were more females (69%) than males (31%). Only 45.5% answered knowledge questions correctly. The adherence level in this study was 64.0%. The major reasons cited for non-adherence included being away from home (23.6%), forgetfulness (17.1%), busy schedule (14%), need to conceal medication (12.7%) and feeling better (11.6%). Conclusion: Patients’ knowledge of ART and adherence to ARVs medicines were sub-optimal. Appropriate strategies to improve patients’ knowledge of ART and adherence to ARVs are recommended.


2008 ◽  
Vol 22 (4) ◽  
pp. 228-240
Author(s):  
Marilou Gagnon ◽  
Dave Holmes

The purpose of this article is to move beyond the biomedical standpoint in the field of HIV/AIDS in order to contribute to the recognition of lipodystrophy as a phenomenon that reaches far beyond its current definition as an unfortunate side effect of highly active antiretroviral therapy (HAART). This article hopes to demonstrate how theory, while remote to the clinical setting, can allow nurses to understand the experience of lipodystrophy as a social phenomenon and address it likewise in their practice. The specific aim of this article is to apply the concept of stigma to the experience of lipodystrophy in people living with HIV/AIDS. The objective of this theoretical piece is to fill the gaps in the way nurses address lipodystrophy in the clinical setting and to demonstrate the richness of Goffman’s concept of stigma (1963) in understanding the experience of lipodystrophy.


2016 ◽  
Vol 5 (56) ◽  
pp. 3872-3876
Author(s):  
Natarajan Kandasamy ◽  
Vijayanand Radhakrishnan ◽  
Ashokkumar Subramanian ◽  
Ravichandran Narayanan ◽  
Mohamed Kalifa Adbul Muthalif ◽  
...  

2015 ◽  
Vol 15 (1) ◽  
Author(s):  
Dickson Shey Nsagha ◽  
Elroy Patrick Weledji ◽  
Nguedia Jules Clement Assob ◽  
Longdoh Anna Njunda ◽  
Elvis Asangbeng Tanue ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document